For recombinant protein and antibody manufacture, cho cells (Chinese hamster ovary cells) have become an industry standard. Their regulatory track record and flexibility also make cho cells valuable tools in pre-clinical research and analytical assay development. By sourcing robust, well-characterised cho cells from Cytion, teams can align lab-scale experiments with bioprocess conditions used later in development.
Why cho cells dominate bioproduction
Several factors explain why cho cells have become the preferred mammalian host for therapeutic protein production:
- Proven history of safe use in licensed biologics
- Capacity for human-like post-translational modifications
- Adaptability to suspension culture and serum-free media
- Amenability to stable cell line development and clonal selection
Researchers who begin with high-quality cho cells are better positioned to translate small-scale results into scalable, regulatory-compliant processes.
Research applications of cho cells beyond manufacturing
Although cho cells are closely associated with manufacturing, they are also widely used in research:
- Expression of recombinant proteins for characterisation and structural studies
- Assay development, where cho cells expressing a target receptor or enzyme support screening campaigns
- Glyco-engineering research, exploring the impact of glycosylation on function and pharmacokinetics
- Comparability studies when evaluating biosimilars or process changes
By integrating cho cells early in assay development, organisations can design workflows that more closely reflect later bioprocessing environments.
Strengths and limitations of cho cells
Using cho cells effectively means balancing their advantages with realistic expectations.
Strengths
- Strong regulatory acceptance worldwide
- Flexible adaptation to diverse culture formats (adherent, suspension, microcarriers)
- Support for high product yields with optimised processes
Limitations
- Non-human origin may affect certain cell–cell interactions or signalling pathways
- Glycosylation patterns, while similar, are not identical to human cells
- Development of stable, high-producing clones can be resource-intensive
These characteristics make cho cells ideal where biomanufacturing relevance is a priority, while other lines may be chosen for specific mechanistic studies.
Practical tips for working with cho cells
To maximise the value of cho cells in the lab:
- Define culture conditions early, including media, feeding strategies and adaptation plans.
- Monitor cell health closely using viability, morphology and growth rate metrics.
- Document clone history and selection criteria for stable lines.
- Implement robust cryopreservation protocols to protect key clones and maintain consistency.
Starting with Cytion’s cho cells provides a solid foundation, with technical information that simplifies optimisation.
How Cytion supports cho-based workflows
Cytion helps researchers and process developers get more from cho cells by:
- Providing authenticated, contamination-free cho cell stocks
- Sharing recommended culture protocols and adaptation guidance
- Offering support in choosing cell lines suited to expression, assay development or early bioprocess research
This comprehensive support allows teams to focus on experimental design and data interpretation, rather than troubleshooting basic culture challenges.
Conclusion: cho cells as a bridge between lab and manufacturing
Whether used for small-scale expression, assay development or early process optimisation, cho cells play a central role in modern biopharmaceutical science. By working with well-characterised cho lines from Cytion and embedding good culture practice, laboratories can generate data that translate more effectively into scalable, compliant biomanufacturing processes.
